$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924009415 Filed on March 26, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$1.999M	$4.983M
YoY Change		750.64%	25.36%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$1.999M	$4.983M
YoY Change		750.64%	25.36%
Operating Profit		-$1.999M	-$5.683M
YoY Change		93.14%	19.02%
Interest Expense		-$2.966M	-$7.182M
YoY Change		-15.74%	16.01%
% of Operating Profit
Other Income/Expense, Net		$551.0K	$2.037M
YoY Change		-273.27%	-161.78%
Pretax Income		-$4.414M	-$9.828M
YoY Change		-9.42%	-31.09%
Income Tax			$0.00
% Of Pretax Income
Net Earnings		-$4.414M	-$9.828M
YoY Change		-9.42%	-31.09%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.27	-$0.61
Diluted Earnings Per Share		-$0.27	-$0.61
COMMON SHARES
Basic Shares Outstanding	16.72M	16.58M	16.22M
Diluted Shares Outstanding			16.22M

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.498M	$9.498M
YoY Change	-50.87%	-50.75%
Cash & Equivalents	$9.498M	$9.498M
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$413.0K	$413.0K
YoY Change	-80.66%	-80.66%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$9.911M	$9.911M
YoY Change	-53.74%	-53.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$971.0K	$971.0K
YoY Change	-24.73%	-24.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$8.497M	$11.69M
YoY Change	-3.95%	-19.62%
Other Assets	$263.0K	$263.0K
YoY Change	-39.4%	-39.4%
Total Long-Term Assets	$12.93M	$12.93M
YoY Change	-20.55%	-20.55%
TOTAL ASSETS
Total Short-Term Assets	$9.911M	$9.911M
Total Long-Term Assets	$12.93M	$12.93M
Total Assets	$22.84M	$22.84M
YoY Change	-39.41%	-39.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$107.0K	$107.0K
YoY Change	568.75%	568.75%
Accrued Expenses	$596.0K	$1.939M
YoY Change	-31.1%	7.66%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.046M	$2.046M
YoY Change	12.6%	12.6%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$50.00K	$810.0K
YoY Change	0.0%	-37.64%
Total Long-Term Liabilities	$50.00K	$810.0K
YoY Change	0.0%	-37.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.046M	$2.046M
Total Long-Term Liabilities	$50.00K	$810.0K
Total Liabilities	$2.856M	$2.856M
YoY Change	-8.34%	-8.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$733.7M
YoY Change	1.36%
Common Stock	$796.1M
YoY Change	-1.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.98M	$19.98M
YoY Change
Total Liabilities & Shareholders Equity	$22.84M	$22.84M
YoY Change	-39.41%	-39.41%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$4.414M	-$9.828M
YoY Change	-9.42%	-31.09%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$808.0K	-$3.308M
YoY Change	35.12%	1.53%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$521.0K	$5.721M
YoY Change	-361.81%	-222.72%
Cash From Investing Activities	$521.0K	$5.721M
YoY Change	-361.81%	-222.72%
FINANCING ACTIVITIES
Cash Dividend Paid		$5.819M
YoY Change
Common Stock Issuance & Retirement, Net		$75.00K
YoY Change		-97.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-5.852M	-$6.252M
YoY Change	546.63%	79.24%
NET CHANGE
Cash From Operating Activities	-808.0K	-$3.308M
Cash From Investing Activities	521.0K	$5.721M
Cash From Financing Activities	-5.852M	-$6.252M
Net Change In Cash	-6.139M	-$3.839M
YoY Change	260.69%	-66.35%
FREE CASH FLOW
Cash From Operating Activities	-$808.0K	-$3.308M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000086115
CY2023	dei	Entity Registrant Name EntityRegistrantName	SAFEGUARD SCIENTIFICS INC
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	4947000
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5478000
CY2022Q4	sfe	Sharebased Compensation Arrangement By Sharebased Payment Award Number Of Award Vesting Types SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfAwardVestingTypes	2	pure
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2023	sfe	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Negative Rate Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateNegativeRatePercent	-0.21	pure
CY2022	sfe	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Negative Rate Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateNegativeRatePercent	-0.21	pure
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2023	sfe	Long Term Incentive Plan Payments LongTermIncentivePlanPayments	0	usd
CY2022	sfe	Long Term Incentive Plan Payments LongTermIncentivePlanPayments	0	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	1-5620
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-1609753
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	150 N. Radnor Chester Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Radnor
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19087
CY2023	dei	City Area Code CityAreaCode	610
CY2023	dei	Local Phone Number LocalPhoneNumber	293-0600
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	21248137	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16722994
CY2023	dei	Auditor Firm AuditorFirmId	248
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	Philadelphia, Pennsylvania
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9498000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13331000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	19000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5956000	usd
CY2023Q4	us-gaap	Trading Securities TradingSecurities	0	usd
CY2022Q4	us-gaap	Trading Securities TradingSecurities	860000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	394000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1251000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9911000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	21423000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	971000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1290000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	11691000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	14545000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	263000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	434000	usd
CY2023Q4	us-gaap	Assets Assets	22836000	usd
CY2022Q4	us-gaap	Assets Assets	37692000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	107000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	854000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	507000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	596000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	865000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	489000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	429000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2046000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1817000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	760000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1249000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	50000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	50000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2856000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3116000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2157000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2157000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	793992000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	804752000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	42418000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	48410000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-733726000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-723898000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19980000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34576000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22836000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37692000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5683000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4775000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-5683000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4775000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2037000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3297000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	903000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	794000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7085000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6985000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9828000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14263000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-9828000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14263000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16221000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16337000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16221000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16337000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	50566000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14263000	usd
CY2022	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-477000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	736000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2940000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34576000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-9828000	usd
CY2023	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	446000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	680000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	75000	usd
CY2023	us-gaap	Dividends Dividends	5819000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19980000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-9828000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14263000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	319000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	271000	usd
CY2023	sfe	Income Loss From Equity Method Investments Excluding Impairments IncomeLossFromEquityMethodInvestmentsExcludingImpairments	-6085000	usd
CY2022	sfe	Income Loss From Equity Method Investments Excluding Impairments IncomeLossFromEquityMethodInvestmentsExcludingImpairments	-6985000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1173000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-0	usd
CY2023	sfe	Gain Loss From Observable Price Changes GainLossFromObservablePriceChanges	1661000	usd
CY2022	sfe	Gain Loss From Observable Price Changes GainLossFromObservablePriceChanges	553000	usd
CY2023	sfe	Gain From Sale Of Ownership Interests GainFromSaleOfOwnershipInterests	542000	usd
CY2022	sfe	Gain From Sale Of Ownership Interests GainFromSaleOfOwnershipInterests	-0	usd
CY2023	sfe	Increase Decrease In Fair Value Of Ownership Interests IncreaseDecreaseInFairValueOfOwnershipInterests	-0	usd
CY2022	sfe	Increase Decrease In Fair Value Of Ownership Interests IncreaseDecreaseInFairValueOfOwnershipInterests	-3689000	usd
CY2023	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	7000	usd
CY2022	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-76000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1121000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1445000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	146000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	534000	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	178000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-374000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3308000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3258000	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3000000	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	-0	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	2851000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	6879000	usd
CY2023	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	250000	usd
CY2022	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	5670000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8530000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	11871000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	14650000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	6000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5721000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4662000	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	5819000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	590000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	207000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	199000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	-0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	75000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2939000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	358000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	549000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6252000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3488000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3839000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-11408000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13356000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24764000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9517000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13356000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9500000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Accounting Estimates</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results <em style="font: inherit;"> may </em>differ from these estimates. These estimates include the evaluation of the recoverability of the Company’s ownership interests and advances, the recoverability of deferred tax assets, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Certain amounts recorded to reflect the Company’s share of income or losses for companies accounted for under the equity method are based on unaudited results of operations of those companies and <em style="font: inherit;"> may </em>require adjustments in the future when audits of these entities’ financial statements are completed.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">It is reasonably possible that the Company’s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company’s ownership interests and advances could change in the near term and that the effect of such changes on the consolidated financial statements could be material. At <em style="font: inherit;"> December 31, 2023</em>, the Company believes the carrying value of the Company’s ownership interests and advances is <em style="font: inherit;">not</em> impaired, although there can be <em style="font: inherit;">no</em> assurance that the Company’s future results will confirm this assessment, that a significant write-down or write-off will <em style="font: inherit;">not</em> be required in the future or that a significant loss will <em style="font: inherit;">not</em> be recorded in the future upon the sale of a company.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"></p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9498000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13331000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	19000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	25000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9517000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13356000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.12	pure
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	500000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	613000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	573000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	619000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	0	usd
CY2023Q4	sfe	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	0	usd
CY2023Q4	sfe	Lessor Operating Lease Payments To Be Received Six Years LessorOperatingLeasePaymentsToBeReceivedSixYears	0	usd
CY2023Q4	sfe	Lessee Operating Lease Liability To Be Paid After Year Six LesseeOperatingLeaseLiabilityToBePaidAfterYearSix	0	usd
CY2023Q4	sfe	Lessor Operating Lease Payment To Be Received After Year Six LessorOperatingLeasePaymentToBeReceivedAfterYearSix	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1439000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1362000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	190000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1249000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	8497000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	8846000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	2805000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	2177000	usd
CY2023Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	389000	usd
CY2022Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	4382000	usd
CY2023Q4	sfe	Investments And Advances To Affiliates Current And Noncurrent InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent	11691000	usd
CY2022Q4	sfe	Investments And Advances To Affiliates Current And Noncurrent InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent	15405000	usd
CY2023Q4	sfe	Equity Method Investment Assets Exceed Carrying Value Of Investment EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment	1100000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1121000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1445000	usd
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1	pure
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.05	pure
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2022	sfe	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Negative Rate Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateNegativeRatePercent	-0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.004	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.026	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.214	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.236	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	24370000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	33222000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	69638000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	68492000	usd
CY2023Q4	sfe	Deferred Tax Asset Disallowed Interest Carryforwards DeferredTaxAssetDisallowedInterestCarryforwards	6613000	usd
CY2022Q4	sfe	Deferred Tax Asset Disallowed Interest Carryforwards DeferredTaxAssetDisallowedInterestCarryforwards	6891000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	13000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	47000	usd
CY2023Q4	sfe	Deferred Tax Liabilities Tax Deferred Benefit Compensation And Benefits Sharebased Compensation Cost DeferredTaxLiabilitiesTaxDeferredBenefitCompensationAndBenefitsSharebasedCompensationCost	-3000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	180000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	66000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-106000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	100697000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	108726000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	100697000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	108726000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	332	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	59	usd
CY2023Q4	sfe	Net Operating Loss Carryforwards Expiring In Year One NetOperatingLossCarryforwardsExpiringInYearOne	50140000	usd
CY2023Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Two NetOperatingLossCarryforwardsExpiringInYearTwo	17408000	usd
CY2023Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Three NetOperatingLossCarryforwardsExpiringInYearThree	7648000	usd
CY2023Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Four NetOperatingLossCarryforwardsExpiringInYearFour	15100000	usd
CY2023Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Five And Thereafter NetOperatingLossCarryforwardsExpiringInYearFiveAndThereafter	182520000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	272816000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-9828000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14263000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16221000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16337000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
CY2023	us-gaap	Profit Loss ProfitLoss	-9828000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14263000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16221000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16337000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
CY2023Q4	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	3800000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	700000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	0	usd
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1500000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1185000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1186000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1313000	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1999000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1185000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1186000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1313000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1999000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-166000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1661000	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	551000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	274000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	249000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	198000	usd
CY2023Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	182000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2564000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1759000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	386000	usd
CY2023Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3148000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3484000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2862000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	932000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4414000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3484000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2862000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	932000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-4414000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1234000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1146000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1360000	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1035000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1234000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1146000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1360000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1035000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1997000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1012000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-318000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	101000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	145000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	230000	usd
CY2022Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	318000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3579000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1454000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1022000	usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3838000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6709000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	483000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3164000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4873000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-6709000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	483000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-3164000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-4873000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.4
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.3
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.4
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.3

Files In Submission

Name	View Source	Status
0001437749-24-009415-index-headers.html	Edgar Link	pending
0001437749-24-009415-index.html	Edgar Link	pending
0001437749-24-009415.txt	Edgar Link	pending
0001437749-24-009415-xbrl.zip	Edgar Link	pending
ex_590125.htm	Edgar Link	pending
ex_590126.htm	Edgar Link	pending
ex_590128.htm	Edgar Link	pending
ex_590129.htm	Edgar Link	pending
ex_590130.htm	Edgar Link	pending
ex_590131.htm	Edgar Link	pending
ex_622654.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20231231.xsd	Edgar Link	pending
sfe20231231_10k.htm	Edgar Link	pending
Show.js	Edgar Link	pending
z01.jpg	Edgar Link	pending
sfe-20231231_def.xml	Edgar Link	unprocessable
sfe-20231231_lab.xml	Edgar Link	unprocessable
sfe-20231231_pre.xml	Edgar Link	unprocessable
sfe20231231_10k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
sfe-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2024 Q1 Form 10-K Financial Statement

#000143774924009415 Filed on March 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2024 Q1 Form 10-K Financial Statement

#000143774924009415 Filed on March 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes